Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdatookt. 2017
StatusUdgivet - okt. 2017
Begivenhed24th Annual Conference of the International Society for Quality of Life Research, - Philadelphia, USA
Varighed: 18. okt. 201721. okt. 2017

Konference

Konference24th Annual Conference of the International Society for Quality of Life Research,
LandUSA
ByPhiladelphia
Periode18/10/201721/10/2017

Citer dette

@conference{c48c7097e87c43739696dbcf38ec4694,
title = "Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research",
author = "{Kongsgaard Nielsen}, Lene",
year = "2017",
month = "10",
language = "English",
note = "null ; Conference date: 18-10-2017 Through 21-10-2017",

}

Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research. / Kongsgaard Nielsen, Lene.

2017. Poster session præsenteret på 24th Annual Conference of the International Society for Quality of Life Research, Philadelphia, USA.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

TY - CONF

T1 - Health-related quality of life in non-transplant eligible newly diagnosed multiple myeloma patients treated with melphalan/prednisolone plus either thalidomide or lenalidomide; results of the HOVON87/NMSG18 study. Quality of Life Research

AU - Kongsgaard Nielsen, Lene

PY - 2017/10

Y1 - 2017/10

M3 - Poster

ER -